Author

Sybille Riou

OpenAlex ID: A5041961908

Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database

2023 · Peter Borchmann, Jan-Michel Heger, et al. · Journal of Cancer Research and Clinical Oncology · 18

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis

2022 · Peter Borchmann, Jan-Michel Heger, et al. · Oncology and Therapy · 15

Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma

2025 · Julia K. Schleifenbaum, Jan-Michel Heger, et al. · Journal of Cancer Research and Clinical Oncology · 5

Identification of Adjustment Variables in Indirect Comparisons: A Rapid Review of CAR-T Therapies for Diffuse Large B-Cell Lymphoma

2025 · Sybille Riou, Stefanie Rungaldier, et al. · Cancers · 3

Survival Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) - Real World Evidence from Germany

2022 · Peter Borchmann, Michael Papadimitrious, et al. · Blood · 2

Covariate selection and adjustment for efficacy and safety endpoints in indirect comparative effectiveness analyses of CAR-T-cell therapies for large B-cell lymphoma: a systematic review

2026 · Marie A-C Neumann, Jonas Jost, et al. · Journal of Comparative Effectiveness Research · 1

Survival outcomes of patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation in Germany: real-world evidence from an administrative database between 2010 and 2019

2024 · Jan-Michel Heger, Peter Borchmann, et al. · Frontiers in Oncology · 1

Systematic Literature Review to Identify Influencing Factors of Efficacy and Safety Outcomes of Chimeric Antigen Receptor T-Cell Therapies in Large B-Cell Lymphoma

2023 · Jan-Michel Heger, Jonas Jost, et al. · Blood · 1

The philosophy of pharmaceutical regulation—Paternalism or freedom of choice?

2023 · Jörg Mahlich, Sybille Riou, et al. · Frontiers in Medicine · 1

Supplementary data: Covariate selection and adjustment for efficacy and safety endpoints in indirect comparative effectiveness analyses of CAR-T-cell therapies for large B-cell lymphoma: a systematic review

2026 · Marie A-C Neumann, Jonas Jost, et al. · Figshare

CO231 Systematic Review of Prognostic Factors for Efficacy and Safety Outcomes in CAR-T Cell Therapy for Diffuse Large B-cell Lymphoma

2025 · Jonas Jost, Jörg Mahlich, et al. · Value in Health

Survival Outcomes of Patients with Diffuse Large B-Cell Lymphoma Who Received Autologous Stem Cell Transplantation in Germany - Real World Evidence from an Administrative Database

2023 · Peter Borchmann, Jan-Michel Heger, et al. · Blood

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma (DLBCL) - a Retrospective Health Claims Data Analysis

2022 · Peter Borchmann, Michael S Papadimitrious, et al. · Blood

Works count: 13

Citation count: 47

H-index: 3

I10-index: 2